This leads to an increase in colon length/body weight ratio, decreased spleen weight/body weight ratio, elevated SOD levels, and reduced MDA levels in serum and intestine, thereby highlighting its therapeutic potential for IBD (89). This evidence concerns the gene SOD1 and irritable bowel syndrome.